• Cardiva Medical (Mountain View, California) reported the addition of two officers to its management team. Malcolm Farnsworth has been named VP of finance and CFO. Tara Zerby joins Cardiva as VP of business development and marketing. Previously, Farnsworth was executive VP and CFO at Point Biomedical. Zerby was formerly VP and general manager of RTI-Cardiovascular. Cardiva is a private company developing vascular access site management and closure devices.
• ev3 (Plymouth, Minnesota) reported the resignation of John Simpson from his position as chief scientist and from the company’s board, effective Feb. 7. “Over the last 30 years, few people have shaped the treatment of cardiovascular disease as much as Dr. John Simpson with his numerous inventions and vision for improving the lives of patients worldwide,” said Jim Corbett, president/CEO and chairman of ev3. “He leaves a legacy of innovation and a foundation on which we intend to build in our effort to improve patient treatment.” With the resignation of Simpson, the ev3 board of directors has nine members, of which six are independent directors. ev3 is a developer of endovascular therapies.
• Nancy McLane has been named senior VP of operations for LifeSync (Fort Lauderdale, Florida). McLane comes to LifeSync after seven years at Cordis. LifeSync is the developer of the LifeSync wireless system, which it describes as the first wireless ECG data communication system appropriate for use in hospital and outpatient settings where cardiac ECG and respiration monitoring are required.
• Richard Brounstein has been named CFO of NewCardio (San Jose, California). Previously, Brounstein was CFO for Certicom. NewCardio’s software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease, as well as cardiac safety assessment of drugs under development.
• David Burkhardt, MD, has been named chief medical officer of Stereotaxis (St. Louis). Burkhardt most recently was associate program director for the clinical cardiac electrophysiology fellowship training program at the Lerner Case Western Reserve School of Medicine at the Cleveland Clinic. Stereotaxis makes a cardiology instrument control system for use in the surgical suite.